miércoles, 18 de diciembre de 2019

Events

FDA Medical Countermeasures Initiative Update

Events

  • January 28-30, 2020: ASM Biothreats (Arlington, VA) - Hosted by the American Society for Microbiology, to offer professionals in biodefense, biosecurity, and biological threats the opportunity to exchange knowledge and ideas, and explore the latest developments and emerging technologies. (fee)
  • New! January 28-29, 2020: HHS Tick-Borne Disease Working Group public meeting (Washington, DC and webcast) - The Working Group will 1) hear presentations from the eight subcommittees on their findings and potential actions for the TBDWG to consider; 2) hear updates from the Public Comment and Inventory Subcommittees; and 3) further discuss plans for developing the 2020 report to the HHS Secretary and Congress on federal tick-borne activities and research. Register in advance.
  • New! February 3, 2020: Advancing EUA IVD Products Toward Full Marketing Status workshop (Silver Spring, MD) - Hosted by the Medical Device Innovation Consortium (MDIC), this workshop will explore key considerations for using real world data (RWD) to generate real world evidence (RWE) to help support in vitro diagnostic (IVD) products available under FDA’s Emergency Use Authorization (EUA) to advance to full marketing status.
  • February 25-26, 2020: Public Workshop - Evolving Role of Artificial Intelligence in Radiological Imaging (Bethesda, MD and webcast) - Through this workshop, FDA is seeking to engage with stakeholders to explore benefits and risks of evolving applications of artificial intelligence (AI) in radiology. Register by 4:00 p.m. ET February 12, 2020.
  • New! February 25-26, 2020: Developing Medical Countermeasures To Treat the Acute and Chronic Effects of Ocular Chemical Toxicity (Rockville, MD) - Development of MCMs that mitigate acute and chronic corneal manifestations in response to ocular toxicants relies on the development of well-characterized experimental models with defined pathophysiology that allow for effective bridging to humans. Such models are also essential to demonstrate therapeutic efficacy. This meeting, sponsored by the NIH Chemical Countermeasures Research Program (CCRP), will bring together subject matter experts from the civilian and military research communities to discuss the current state of the field, including potential therapeutic approaches and available models. Register by January 31, 2020.
  • March 3, 2020: Public workshop - Facilitating End-to-End Development of Individualized Therapeutics (Silver Spring, MD and webcast) - To foster development of individualized therapeutic products for the treatment of one individual or a very small number of patients, based on engineering a product aimed at the specific molecular mechanism underlying a patient’s (or small group of patients’) illness. To attend in person, register by February 18, 2020.
  • March 18-19, 2020: Joint Civil & DoD CBRN Symposium (Alexandria, VA) - Hosted by the Defense Strategies Institute, to provide a forum for CBRN stakeholders to discuss the latest updates in advancing a government-wide approach to improving CBRN defense, readiness and response strategies and capabilities. (fee)
  • March 31 - April 3, 2020: Preparedness Summit (Dallas, TX) - Hosted by the National Association of County & City Health Officials (NACCHO), the Summit offers a unique learning and networking opportunity for current and aspiring emergency management, public health, and healthcare professionals, and their partners, to share perspectives and engage in dialogue on key public health preparedness and response issues. (fee)

No hay comentarios: